trihexyphenidyl has been researched along with Coma in 2 studies
Trihexyphenidyl: One of the centrally acting MUSCARINIC ANTAGONISTS used for treatment of PARKINSONIAN DISORDERS and drug-induced extrapyramidal movement disorders and as an antispasmodic.
Coma: A profound state of unconsciousness associated with depressed cerebral activity from which the individual cannot be aroused. Coma generally occurs when there is dysfunction or injury involving both cerebral hemispheres or the brain stem RETICULAR FORMATION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Geller, B | 1 |
| Greydanus, DE | 1 |
| Grunhaus, L | 1 |
| Sancovici, S | 1 |
| Rimon, R | 1 |
2 other studies available for trihexyphenidyl and Coma
| Article | Year |
|---|---|
Haloperidol-induced comatose state with hyperthermia and rigidity in adolescence: two case reports with a literature review.
Topics: Adolescent; Child; Child Behavior Disorders; Coma; Female; Fever; Haloperidol; Humans; Male; Muscle | 1979 |
Neuroleptic malignant syndrome due to depot fluphenazine.
Topics: Adult; Coma; Delayed-Action Preparations; Dyskinesia, Drug-Induced; Fever; Fluphenazine; Humans; Mal | 1979 |